title: [Testosterone substitution with special regard to prostate cancer].
abstract: Testosterone substitution is used to treat the symptoms of low testosterone in men who do not produce enough natural testosterone. Hypogonadism is associated with a range of disease states that have significant effects on morbidity and mortality and also affect quality of life. The regular investigation of PSA, prostate, and ultrasound is necessary.
authors.affiliation: Urologische Klinik, Südharz-Krankenhaus gGmbH Nordhausen, Dr.-R.-Koch-Strasse 39, 99734 Nordhausen. Matthias.beintker@shk-ndh.de
authors.forename: M
authors.initials: M
authors.lastname: Beintker
authors.forename: H
authors.initials: H
authors.lastname: Behre
mesh_terms: D000328:Adult; D000368:Aged; D047649:Andropause / Q000187:drug effects*; D003131:Combined Modality Therapy; D018450:Disease Progression; D004305:Dose-Response Relationship, Drug; D020249:Hormone Replacement Therapy / Q000379:methods*; D006801:Humans; D007006:Hypogonadism / Q000097:blood / Q000188:drug therapy*; D008297:Male; D008403:Mass Screening; D008875:Middle Aged; D011471:Prostatic Neoplasms / Q000097:blood / Q000139:chemically induced* / Q000175:diagnosis; D012307:Risk Factors; D013739:Testosterone / Q000009:adverse effects / Q000172:deficiency* / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D013739:Testosterone